Piezoelectric Sensor Measures Antibiotic Efficacy
|
By HospiMedica International staff writers Posted on 25 Oct 2017 |

Image: Dr. Ward Johnson observes signals generated by bacteria coating quartz crystals (Photo courtesy of Burrus / NIST.
A new study claims that a quartz-based sensor could determine within an hour if an antibiotic will be effective against an infection.
The novel piezoelectric resonator, developed by researchers at the U.S. National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA), is extremely sensitive, and can detect the mechanical motion of microbes adhered to it, and their response to antibiotics. The sensor is composed of a thin piezoelectric quartz disk sandwiched between two electrodes. An alternating voltage at a stable frequency--near the crystal's resonant frequency--is applied to one electrode to excite crystal vibrations.
At the other electrode (on the opposite side of the crystal), oscillating voltages resulting from crystal response can be recorded; the fluctuations in the resonant frequency result from microbial mechanical activity of the several million bacterial cells coupled to the crystal surface. The ultra-sensitive approach can enable detection of cell-generated frequency fluctuations at a level of less than one part in 10 billion, with the amount of frequency noise generated correlating with the density of the living bacterial cells.
When E. coli bacteria were exposed to different antibiotics, the sensor showed that the frequency noise from the bacteria fell to zero within seven minutes of being treated with polymyxin B, and within 15 minutes of receiving ampicillin; the results mirrored the normal pharmacokinetics of the antibiotic drugs. The researchers added that since they used bacteria with paralyzed flagella, they concluded that the frequency fluctuations resulted from vibrations of cell walls. The study was published on September 22, 2017, in Nature Scientific Reports.
“Current tests require colonies of bacteria to be cultured for days, which can allow an improperly treated infection to advance and give the bacteria a chance to develop drug resistance,” concluded lead author Ward Johnson, PhD. “The NIST sensor is a quartz-crystal resonator that vibrates differently when bacterial cells on its surface change their behavior; it detects the mechanical motion of microbes to gauge a response to antibiotics…the amount of frequency noise emitted by the bacterial cells increased with the density of bacteria.”
Piezoelectricity, discovered in 1880 by French physicists Jacques and Pierre Curie, is a reversible effect in crystals that describes the internal generation of an electrical charge resulting from a mechanical force. For example, lead zirconate titanate crystals will generate measurable piezoelectricity when their static structure is deformed by about 0.1%. Conversely, the same crystals will change about 0.1% of their static dimension when an external electric field is applied to the material. The inverse piezoelectric effect is used in the production of ultrasonic sound waves.
Related Links:
National Institute of Standards and Technology
The novel piezoelectric resonator, developed by researchers at the U.S. National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA), is extremely sensitive, and can detect the mechanical motion of microbes adhered to it, and their response to antibiotics. The sensor is composed of a thin piezoelectric quartz disk sandwiched between two electrodes. An alternating voltage at a stable frequency--near the crystal's resonant frequency--is applied to one electrode to excite crystal vibrations.
At the other electrode (on the opposite side of the crystal), oscillating voltages resulting from crystal response can be recorded; the fluctuations in the resonant frequency result from microbial mechanical activity of the several million bacterial cells coupled to the crystal surface. The ultra-sensitive approach can enable detection of cell-generated frequency fluctuations at a level of less than one part in 10 billion, with the amount of frequency noise generated correlating with the density of the living bacterial cells.
When E. coli bacteria were exposed to different antibiotics, the sensor showed that the frequency noise from the bacteria fell to zero within seven minutes of being treated with polymyxin B, and within 15 minutes of receiving ampicillin; the results mirrored the normal pharmacokinetics of the antibiotic drugs. The researchers added that since they used bacteria with paralyzed flagella, they concluded that the frequency fluctuations resulted from vibrations of cell walls. The study was published on September 22, 2017, in Nature Scientific Reports.
“Current tests require colonies of bacteria to be cultured for days, which can allow an improperly treated infection to advance and give the bacteria a chance to develop drug resistance,” concluded lead author Ward Johnson, PhD. “The NIST sensor is a quartz-crystal resonator that vibrates differently when bacterial cells on its surface change their behavior; it detects the mechanical motion of microbes to gauge a response to antibiotics…the amount of frequency noise emitted by the bacterial cells increased with the density of bacteria.”
Piezoelectricity, discovered in 1880 by French physicists Jacques and Pierre Curie, is a reversible effect in crystals that describes the internal generation of an electrical charge resulting from a mechanical force. For example, lead zirconate titanate crystals will generate measurable piezoelectricity when their static structure is deformed by about 0.1%. Conversely, the same crystals will change about 0.1% of their static dimension when an external electric field is applied to the material. The inverse piezoelectric effect is used in the production of ultrasonic sound waves.
Related Links:
National Institute of Standards and Technology
Latest Critical Care News
- Angiography-Based FFR Approach Matches Gold Standard Results Without Wires
- Eye Imaging AI Identifies Elevated Cardiovascular Risk
- Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreSurgical Techniques
view channel
Fiber-Form Bone Graft Expands Intraoperative Options for Spinal Fusion
Spinal and orthopedic fusion procedures often require bone graft materials that handle predictably and support bone formation. Surgeons face added complexity in difficult anatomy and challenging fusion environments.... Read more
Ultrasound‑Aided Catheter Treatment Cuts Early Collapse in Pulmonary Embolism
Acute pulmonary embolism can cause rapid hemodynamic deterioration and early death in hospitalized and emergency patients. Systemic thrombolysis can dissolve clots but is limited by a high risk of major... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
Voice-Driven AI System Enables Structured GI Procedure Documentation
Documentation during gastrointestinal (GI) procedures often competes with real-time clinical decision-making and imposes a significant cognitive burden on physicians. Manual data entry and post-procedure... Read more
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







